Programs
Breast Cancer
Colorectal Cancers
ctDNA/MRD
Genitourinary Cancers
GI Cancers
Biliary Tract Cancers
Gastroesophageal Cancers
Liver Cancer
Pancreatic Cancer
Gynecologic Cancer
Hematologic Cancers
Lung Cancer
Melanoma
Precision Medicine
ALK
BRAF
BRCA
c-MET
EGFR
ESR1
FGFR
HER2
KRAS
MTAP
NRG1 Fusions
NTRK Fusions
Faculty
Tumor Boards
Newsletters
Resources
About Us
Search
Colorectal Cancers
Targeting HER2 in Colorectal Cancer
John Strickler, MD
ctDNA Positivity after Resection of a Stage III Colon Cancer: Practice Changing Results from a Cooperative Group Trial
John Strickler, MD
Updates on Management of MSI-H Colon Cancer
John Strickler, MD
Key Advances in the Management of Colorectal Cancer – Novel TKIs and their role in the treatment sequence of advanced CRC
Tanios S. Bekaii-Saab, MD
Management of Advanced HER2 Positive Colon Cancer
Sakti Chakrabarti, MD
Fruquintinib – The Next Advance in Management for Advanced CRC
Sakti Chakrabarti, MD
Previous Page
1
2
3
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website